Home / Products / API / Details
video
Lapatinib Ditosylate Powder

Lapatinib Ditosylate Powder

Appearance: White crystalline powder
Specification: 99%
CAS:388082-78-8 
Molecular Formula: C41H40ClFN4O11S3
Molecular Weight: 925.46
Shelf Life: 2 Years Proper Storage
Stock: Adequate Stock
Certificate: ISO,GMP, HACCP SGS
Service: OEM Service(Private Package)

Product Introduction

Xi'an Sonwu Biotech Co., Ltd. is one of the most professional manufacturers and suppliers of lapatinib ditosylate powder in China. We warmly welcome yuo to wholesale bulk lapatinib ditosylate powder for sale here from our factory. Quality products and reasonable price are available.

 

What Is Lapatinib Ditosylate Explained

Lapatinib ditosylate Powder,also known as Tykerb Powder. It is a medication used to treat certain types of breast cancer. It is a tyrosine kinase inhibitor, which means it blocks the action of tyrosine kinase enzymes that are involved in the growth and spread of cancer cells. It is specifically used to treat breast cancers that are HER2-positive. HER2 is a protein that is overproduced in some types of breast cancer cells and promotes their growth. By blocking HER2 and other tyrosine kinases, Tykerb can slow or stop the growth of these cancer cells. And it is typically taken orally, as a tablet. It is usually used in combination with another medication, such as capecitabine or letrozole, to increase its effectiveness. The dosage and duration of treatment may vary depending on the individual patient's condition and response to the medication. Like all medications, Tykerb may cause side effects. Common side effects include diarrhea, nausea, vomiting, fatigue, and skin rash. More serious side effects may include liver problems, heart problems, and lung problems. Patients taking Tykerb should be closely monitored for any signs of these side effects. It is important to note that Tykerb is not a cure for breast cancer. It is intended to slow or stop the growth of cancer cells and may be used as part of a larger treatment plan that may include surgery, radiation therapy, and other medications.

Lapatinib Ditosylate Powder mf


Tykerb is a relatively new medication and is still being studied to determine its long-term effectiveness and safety. However, early studies have shown promising results, particularly when used in combination with other medications. In conclusion, it is a medication used to treat certain types of breast cancer by blocking the action of tyrosine kinase enzymes. It is generally well-tolerated, but may cause side effects that should be closely monitored. Tykerb is not a cure for breast cancer, but may be used as part of a larger treatment plan to slow or stop the growth of cancer cells. The purity of our product is 99%, the raw materials are selected well, and the price is also very preferential. If you are interested in our products, just contact Xi'an Sonwu Biotech Co., Ltd.


Certificate of Analysis

ANALYSIS

SPECIFICATION

RESULT

Appearance

White crystalline powder

Complies

Identification

IR

3.4%

Specific Rotation

+22~+26°

+23.09°

Loss on drying

0.5%max

0.25%

Residue On Ignition

0.1%max

Complies

Heavy Metals

≤20ppm

Complies

Organic Volatile Impurities

Meets the requirement.

Conforms

Related Substances

Individual Impurities: ≤1.5%

0. 15%

Total Impurities: ≤ 2.0%

0.22%


Assay

≥99.0%

99.68%

Conclusion

Conform with specification



Where To Buy Lapatinib Ditosylate

Xi'an Sonwu has rich experience in the global trade and health industry. Credit-based and quality first is the principle of Xi'an Sonwu company. Xi'an Sonwu strictly controls product quality, so the selection starts with raw materials. In addition, we handle every detail and minimize costs so that our customers can get the most cost-effective products. Based on these, customers have given high praise to our products . So find Xi'an Sonwu BiotechCo., Ltd when buying the Lapatinib Ditosylate Powder.


Xi'an Sonwu completely makes sure of the product's quality, so samples can be supplied. Here is the quantity.

Form

Sample Amount

The Minimum of Quantity

Powder

5g

10g

Customers' Good Comment

Customers Good Comment


What Is The Solubility of Lapatinib Ditosylate

Tykerb is a medication that has been developed to treat a number of different types of cancer, including breast cancer, lung cancer, and brain cancer. The medication works by inhibiting the activity of certain enzymes in the body called tyrosine kinases, which are involved in the growth and spread of cancer cells. While Tykerb has shown promise in treating these cancers, it has been found to have low solubility in water. The solubility of a medication is an important factor in determining its effectiveness, as it affects the rate and extent of absorption into the bloodstream. Medications that have low solubility can be more difficult for the body to absorb, which can lead to less effective treatment outcomes. Therefore, efforts are made to improve the solubility of medications, including those like Tykerb. The solubility of Tykerb has been studied extensively in laboratories, with researchers testing the medication's solubility in various solvents under different conditions. One of the most commonly used solvents is water, as this is the most abundant solvent in the body. Studies have shown that the solubility of Tykerb in water is less than 0.5 mg/mL at 25°C. This is considered to be low solubility, and it presents a challenge for formulating the medication into a dosage form that can be effectively absorbed by patients and provide the desired therapeutic effect. To address the issue of low solubility, researchers have investigated different formulation approaches that can improve the solubility and bioavailability of Tykerb. One such approach is to formulate the medication as an oral tablet, where Tykerb is combined with other excipients (inactive ingredients) that can enhance its solubility and absorption. For example, one study found that the addition of a surfactant to Tykerb tablets improved the solubility of the medication by up to 2.5 times. The study also showed that the bioavailability of the medication was significantly improved, meaning that more of the medication was absorbed by the body and made available to treat cancer cells. In addition to tablets, Tykerb is also available in other dosage forms such as an oral suspension, which is used for patients who have difficulty swallowing tablets. The oral suspension is formulated with a mixture of water and glycerin to improve the solubility of the medication. In conclusion, the low solubility of Tykerb has been identified as a challenge in formulating the medication to be effectively absorbed by patients and provide the desired therapeutic effect. Researchers have explored different formulation approaches, such as using surfactants and glycerin, to improve the solubility and bioavailability of Tykerb and enhance its effectiveness as a treatment for cancer.

Lapatinib Ditosylate Powder effect3 (2)


What Is Lapatinib Ditosylate Used For

Lapatinib ditosylate (Tykerb) is a medication primarily used to treat certain types of breast cancer. Specifically, it is used to treat breast cancers that are HER2-positive. HER2-positive breast cancer is a type of breast cancer in which the cancer cells produce too much of a protein called HER2. This protein promotes the growth and spread of cancer cells, making HER2-positive breast cancer more aggressive than other types of breast cancer. Tykerb works by blocking the action of tyrosine kinase enzymes, including HER2, that are involved in the growth and spread of cancer cells. By blocking these enzymes, Tykerb can slow or stop the growth of HER2-positive breast cancer cells. Tykerb is often used in combination with other medications, such as capecitabine or letrozole, to increase its effectiveness. When used with capecitabine, Tykerb is typically used for the treatment of advanced or metastatic breast cancer that has not responded to other treatments. When used with letrozole, Tykerb is typically used for the treatment of postmenopausal women with hormone receptor-positive, HER2-positive advanced or metastatic breast cancer. In addition to HER2-positive breast cancer, there is some evidence that Tykerb may be effective in treating other types of cancer, such as advanced gastric cancer and non-small cell lung cancer. However, more research is needed to confirm these findings. It is important to note that Tykerb is not a cure for breast cancer or any other type of cancer. It is intended to slow or stop the growth of cancer cells and may be used as part of a larger treatment plan that may include surgery, radiation therapy, and other medications. Like all medications, Tykerb may cause side effects. Common side effects include diarrhea, nausea, vomiting, fatigue, and skin rash. More serious side effects may include liver problems, heart problems, and lung problems. Patients taking Tykerb should be closely monitored for any signs of these side effects. In conclusion, Tykerb is primarily used to treat HER2-positive breast cancer by blocking the action of tyrosine kinase enzymes involved in the growth and spread of cancer cells. It may be used in combination with other medications as part of a larger treatment plan. Tykerb is not a cure for breast cancer or any other type of cancer, and may cause side effects that should be closely monitored.

Lapatinib Ditosylate Powder effect2 (2)


Is Lapatinib Toxic To The Liver

Tykerb is a medication that has been developed to treat certain types of cancer, including breast cancer and lung cancer. While the medication has shown promise in treating these conditions, concern has been raised about its potential toxicity to the liver. The liver plays an important role in metabolizing medications and removing toxins from the body. When medications are metabolized in the liver, they can produce by-products that may be toxic to the liver if they accumulate in high concentrations. In addition, some medications can directly damage liver cells, leading to liver toxicity. To determine if Tykerb is toxic to the liver, researchers have conducted studies to assess the medication's effects on liver function and structure. Several clinical trials have evaluated the safety and efficacy of Tykerb in patients with advanced breast cancer and other types of cancer. One study found that Tykerb treatment was associated with elevated levels of liver enzymes in the blood, which is a sign of liver damage. However, the study concluded that the elevation in liver enzyme levels was transient and did not result in clinically significant liver toxicity. Another study found that Tykerb treatment was associated with a slight increase in the risk of liver toxicity compared to placebo. However, the risk was considered to be low and the overall incidence of liver toxicity was still relatively rare, occurring in less than 1% of patients. It is worth noting that patients with preexisting liver disease or those taking other medications that can affect liver function may be at a higher risk of experiencing liver toxicity from Tykerb. Therefore, it is important for physicians to closely monitor liver function in patients receiving Tykerb, particularly those with underlying liver disease or taking other medications that can affect liver function. In conclusion, while Tykerb has been associated with elevated liver enzyme levels and a slight increase in the risk of liver toxicity in some studies, the overall risk of liver toxicity appears to be low. Physicians should monitor liver function in patients receiving Tykerb, particularly those with preexisting liver disease or taking other medications that can affect liver function.

anemia effect


What Is The Mechanism of Action of Lapatinib Ditosylate

Tykerb is a medication that works by blocking the action of certain enzymes in the body called tyrosine kinases. These enzymes are involved in the growth and spread of cancer cells, which is why Tykerb is primarily used to treat certain types of breast cancer. More specifically, Tykerb is known as a tyrosine kinase inhibitor. It is designed to bind to specific proteins on the surface of cancer cells, including HER2 (human epidermal growth factor receptor 2) and EGFR (epidermal growth factor receptor). These proteins are often overproduced in certain types of cancer cells, including HER2-positive breast cancer, and their overproduction can drive the growth and spread of cancer. When Tykerb binds to these proteins, it blocks their activity and prevents them from sending signals that promote the growth and spread of cancer cells. By inhibiting the activity of these proteins, Tykerb can slow or stop the growth of cancer cells and, in some cases, shrink tumors. In addition to its effects on HER2 and EGFR, Tykerb has also been shown to inhibit other tyrosine kinases that are involved in cancer cell growth and survival, including HER4, Src, and Abl. By targeting multiple tyrosine kinases, Tykerb may have a broader anti-cancer effect than medications that target only one enzyme. It is important to note that Tykerb is not effective for all types of breast cancer, but rather is specifically indicated for HER2-positive breast cancer. Not all breast cancers produce an overabundance of HER2, so Tykerb would not be effective for those types of cancer. In conclusion, Tykerb is a medication that works by inhibiting the activity of specific proteins on the surface of cancer cells, including HER2 and EGFR, as well as other tyrosine kinases. By blocking these proteins, Tykerb can slow or stop the growth of cancer cells and shrink tumors in some cases. Tykerb is primarily indicated for the treatment of HER2-positive breast cancer.

Lapatinib Ditosylate Powder ACTION1


Factory Environment

Xi'an Sonwu Biotech Co.,Ltd has its own factory,so it has adequate stock. Also,Xi'an Sonwu has clean and tidy producing department with advanced equipment. With the lead of Xi'an Sonwu, researchers are constantly developing new products to meet customer's need. Xi'an Sonwu Biotech Co.,Ltd has advanced test equipment and professional testers, which all show that Xi'an Sonwu aims to supply accurate and effective data and good service.

Lapatinib Ditosylate Powder factory environment


Certificates

Lapatinib Ditosylate Powder certificates


Packaging

Lapatinib Ditosylate Powder Packaging


Logistics

Logistics Record

Except guarantee the product's, the other most important thing is customers could receive the goods smoothly. So, Xi'an Sonwu supply all kinds of courier according to different need.

courier of Lapatinib Ditosylate Powder


Why Choose Us

Our company has been engaged in import-export for over 10 years and has rich experience in import and export industry.

Our company has 10-year experience in product development, production and sales.

Our company has a professional team with clear division of labor.

We have professional laboratories and equipment to ensure high quality products.

Products are tested by third parties.

We provide 7*24 customer service.


If you want to know the Lapatinib Ditosylate Powder price, please contact us online via:

E-mail:sales@sonwu.com

Hot Tags: lapatinib ditosylate powder, China, suppliers, manufacturers, factory, wholesale, buy, price, bulk, pure, raw, supply, for sale, Fasoracetam Powder, 9 ME BC Powder, Pure Pregabalin Powder, Monobenzone Raw Powder, 5 HTP Powder, Tryptamine Powder

Send Inquiry

whatsapp

teams

E-mail

Inquiry

Bag